.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
A systematic review and meta-analysis examined whether blood eosinophil count can help predict the effect of inhaled corticosteroids on exacerbation risk in COPD. The investigators synthesized randomized and observational evidence using commonly studied eosinophil thresholds. Across randomized trial data, higher blood eosinophil counts were associated with a greater likelihood of exacerbation reduction with ICS-containing treatment, while the observational evidence was more heterogeneous. The practical implication is that eosinophil count can support, but should not replace, clinical decision-making. It is particularly useful when deciding whether to introduce, continue, or withdraw an ICS in a patient whose exacerbation history, smoking status, pneumonia risk, and possible asthma overlap are already being considered. The analysis also supports the broader shift away from treating COPD as a single spirometric phenotype. Blood eosinophils are a low-burden biomarker that can add information when the treatment decision is uncertain. For clinicians attending a conference session on phenotyping and ICS decisions, the paper offers a useful evidence base for using biomarkers as part of a structured assessment rather than as a stand-alone prescription trigger.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A systematic review and meta-analysis examined whether blood eosinophil count can help predict the effect of inhaled corticosteroids on exacerbation risk in COPD. The investigators synthesized randomized and observational evidence using commonly studied eosinophil thresholds. Across randomized trial data, higher blood eosinophil counts were associated with a greater likelihood of exacerbation reduction with ICS-containing treatment, while the observational evidence was more heterogeneous. The practical implication is that eosinophil count can support, but should not replace, clinical decision-making. It is particularly useful when deciding whether to introduce, continue, or withdraw an ICS in a patient whose exacerbation history, smoking status, pneumonia risk, and possible asthma overlap are already being considered. The analysis also supports the broader shift away from treating COPD as a single spirometric phenotype. Blood eosinophils are a low-burden biomarker that can add information when the treatment decision is uncertain. For clinicians attending a conference session on phenotyping and ICS decisions, the paper offers a useful evidence base for using biomarkers as part of a structured assessment rather than as a stand-alone prescription trigger.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
2 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
3 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
3 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
3 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
3 days back
